Neutrophil extracellular traps (NETs)-mediated killing of carbapenem-resistant hypervirulent Klebsiella pneumoniae (CR-hvKP) are impaired in patients with diabetes mellitus
- PMID: 32865110
- PMCID: PMC7549946
- DOI: 10.1080/21505594.2020.1809325
Neutrophil extracellular traps (NETs)-mediated killing of carbapenem-resistant hypervirulent Klebsiella pneumoniae (CR-hvKP) are impaired in patients with diabetes mellitus
Abstract
Carbapenem-resistant hypervirulent Klebsiella pneumoniae (CR-hvKP) have been reported in recent years across Asian countries and pose a serious threat to public health. Neutrophils represent the first line of defense against numerous infectious pathogens, such as CR-hvKP. Neutrophil extracellular traps (NETs) constitute one of the major antimicrobial defense mechanisms in neutrophils against invading pathogens, especially against hvKP. Interestingly, previous studies have demonstrated that patients with type 2 diabetes mellitus (T2D) display elevated levels of NETosis but are vulnerable to infections caused by hvKP. The discrepancy propels us to investigate the role of NETs in hvKP infections in the context of T2D. By utilizing a clinical-derived CR-hvKP strain and a combination of NETs complex detection, phagocytosis testing, NETs killing assay and immunofluorescence, and scanning electron microscope assays, we identified defective NETs-mediated killing of CR-hvKP strain in patients with T2D. Specifically, we show that the impaired NETs-mediated killing in T2D is not due to the decreased NETs formation, as the neutrophils isolated from T2D patients exhibited enhanced NETs formation compared to healthy controls. Further, we demonstrate that the reduced NETs activity does not result from the trapping failure of CR-hvKP, but likely associated with the deficient surface damage conferred by the NETs of T2D patients. Our data provide a novel insight into the defective innate immune response against CR-hvKP in T2D.
Keywords: Neutrophil extracellular traps (NETs); antimicrobial activity; carbapenem-resistant hypervirulent Klebsiella pneumoniae (CR-hvKP); innate immunity; type 2 diabetes mellitus (T2D).
Conflict of interest statement
All authors have no financial conflicts of interest.
Figures
Similar articles
-
Resistance of hypervirulent Klebsiella pneumoniae to both intracellular and extracellular killing of neutrophils.PLoS One. 2017 Mar 10;12(3):e0173638. doi: 10.1371/journal.pone.0173638. eCollection 2017. PLoS One. 2017. PMID: 28282434 Free PMC article.
-
Isolation and characterization of a sequence type 25 carbapenem-resistant hypervirulent Klebsiella pneumoniae from the mid-south region of China.BMC Microbiol. 2019 Sep 18;19(1):219. doi: 10.1186/s12866-019-1593-5. BMC Microbiol. 2019. PMID: 31533609 Free PMC article.
-
Comparison of Diabetic and Non-diabetic Human Leukocytic Responses to Different Capsule Types of Klebsiella pneumoniae Responsible for Causing Pyogenic Liver Abscess.Front Cell Infect Microbiol. 2017 Sep 7;7:401. doi: 10.3389/fcimb.2017.00401. eCollection 2017. Front Cell Infect Microbiol. 2017. PMID: 28936426 Free PMC article.
-
A global perspective on the convergence of hypervirulence and carbapenem resistance in Klebsiella pneumoniae.J Glob Antimicrob Resist. 2021 Jun;25:26-34. doi: 10.1016/j.jgar.2021.02.020. Epub 2021 Mar 2. J Glob Antimicrob Resist. 2021. PMID: 33667703 Review.
-
"Superbugs" with hypervirulence and carbapenem resistance in Klebsiella pneumoniae: the rise of such emerging nosocomial pathogens in China.Sci Bull (Beijing). 2023 Nov 15;68(21):2658-2670. doi: 10.1016/j.scib.2023.09.040. Epub 2023 Sep 29. Sci Bull (Beijing). 2023. PMID: 37821268 Review.
Cited by
-
Phenotypic and genetic characterization of hypervirulent Klebsiella pneumoniae in patients with liver abscess and ventilator-associated pneumonia.BMC Microbiol. 2023 Nov 13;23(1):338. doi: 10.1186/s12866-023-03022-5. BMC Microbiol. 2023. PMID: 37957579 Free PMC article.
-
Clinical and genomic analysis of hypermucoviscous Klebsiella pneumoniae isolates: Identification of new hypermucoviscosity associated genes.Front Cell Infect Microbiol. 2023 Jan 4;12:1063406. doi: 10.3389/fcimb.2022.1063406. eCollection 2022. Front Cell Infect Microbiol. 2023. PMID: 36683676 Free PMC article.
-
Host defense against the infection of Klebsiella pneumoniae: New strategy to kill the bacterium in the era of antibiotics?Front Cell Infect Microbiol. 2022 Nov 24;12:1050396. doi: 10.3389/fcimb.2022.1050396. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36506034 Free PMC article. Review.
-
Phenotypic and Genomic Comparison of Staphylococcus aureus Highlight Virulence and Host Adaptation Favoring the Success of Epidemic Clones.mSystems. 2022 Dec 20;7(6):e0083122. doi: 10.1128/msystems.00831-22. Epub 2022 Nov 21. mSystems. 2022. PMID: 36409083 Free PMC article.
-
Hypervirulent carbapenem-resistant Klebsiella pneumoniae causing highly fatal meningitis in southeastern China.Front Public Health. 2022 Oct 17;10:991306. doi: 10.3389/fpubh.2022.991306. eCollection 2022. Front Public Health. 2022. PMID: 36324461 Free PMC article.
References
-
- Wang Q, Wang X, Wang J, et al. Phenotypic and genotypic characterization of carbapenem-resistant Enterobacteriaceae: data from a longitudinal large-scale CRE study in China (2012-2016). Clin Infect Dis. 2018;67:S196–S205. - PubMed
-
- Gu D, Dong N, Zheng Z, et al. A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a chinese hospital: a molecular epidemiological study. Lancet Infect Dis. 2018;18(1):37–46. . - PubMed
-
- Zhang Y, Jin L, Ouyang P, et al. Evolution of hypervirulence in carbapenem-resistant Klebsiella pneumoniae in china: a multicentre, molecular epidemiological analysis. J Antimicrob Chemother. 2020;75:327–336. - PubMed
-
- Carey IM, Critchley JA, DeWilde S, et al. Risk of infection in type 1 and type 2 diabetes compared with the general population: a matched cohort study. Diabetes Care. 2018;41:513–521. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
